Department of Medicine

December 13, 2021

Oral microbes and gastric cancer

Studies in three large population cohorts that include Asian, African American and European American people support a role for the oral microbiota — the collection of microbial species in the mouth — in gastric cancer development.

By Leigh MacMillan
PHOTO: Members of the supermere discovery team include (front row from left) Qi Liu, PhD, Robert Coffey, MD, Qin Zhang, PhD, and (back row from left) James Higginbotham, PhD; Dennis Jeppesen, PhD; and Jeffrey Franklin, PhD. (hoto by Erin O. Smith)
December 10, 2021

“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19

Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.

By Bill Snyder
December 9, 2021

Cell signaling targets in leukemia

Vanderbilt researchers identified a critical role for IL-1beta signaling in leukemia cells with a certain mutation, suggesting this pathway may be a good target for novel treatments.

By Leigh MacMillan
December 2, 2021

Gene discoveries give new hope to people who stutter

New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter.

By Bill Snyder
December 2, 2021

Study links depression scores, white blood cell count

By Emily Stembridge
December 2, 2021

Reid selected for clinical trial development program

Vanderbilt’s Sonya Reid, MD, MPH, has been selected to participate in the first cohort of the Bristol Myers Squibb Foundation Clinical Trial Diversity Career Development Program.

By Tom Wilemon
November 30, 2021

Department of Medicine December Grand Rounds announced

By VUMC News and Communications
November 30, 2021

Study examines genetic risk for suicide attempt

New research from Vanderbilt identifies the first replicated genomic region contributing to risk of suicide attempt and confirms that genetic risk for the trait is not driven solely by risk for psychiatric disorders.
By Paul Govern
November 18, 2021

‘Multi-omics’ reveals treatment option for breast cancer subtype

By Bill Snyder
November 18, 2021

Seven from VUMC among most highly cited researchers

Seven Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers.
By Bill Snyder
November 15, 2021

New Department of Medicine roles push forward initiatives in clinical research

T. Alp Ikizler, MD, director of Vanderbilt's Division of Nephrology and Hypertension, has been named vice chair for Clinical Research in the Department of Medicine.
By Emily Stembridge
November 15, 2021

Who’s who in the respiratory landscape

A metatranscriptomics method developed by Vanderbilt researchers simultaneously characterizes viruses, microbiome and host response in nasal swabs, opening opportunities to explore molecular interactions directly in clinical samples.
By Leigh MacMillan
November 11, 2021

VUMC team puts tool to reduce heart failure admissions to test

Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.
By Bill Snyder
1 … 31 32 33 34 35 … 100